Matches in SemOpenAlex for { <https://semopenalex.org/work/W2562839908> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2562839908 abstract "Abstract The current experience in the use of multiparametric flow-cytometry for immunological detection of MRD in AML, indicates that the method is feasible, rapid and relatively sensitive. In our previous studies of AML patients with aberrant phenotype (Blood 2000, Leukemia 2003 & 2006), we found that the level of MRD after consolidation therapy was the best predictor of outcome. In fact, a MRD level higher than 3.5x10−4 residual leukemic cells after consolidation was significantly correlated with a poor outcome. The major problem with using an empirically established cut-off to define thresholds is that it may not be reproducible over different populations of patients. In order to confirm the prognostic value of the threshold of 3.5x10−4 residual leukemic cells, previously selected, we used the Maximally Selected Rank Statistic analysis to determine optimal cutpoint, yielding the best separation of AML patients into two groups with different OS and/or RFS probabilities. To do this, we evaluated the trend of standardized log-rank statistics using RFS (Fig. 1, upper panels) and OS (Fig. 1, lower panels) as dependent variables, and the values of residual leukemic cells, determined both at the post-Induction (post-Ind) and post-consolidation (post-Cons) checkpoints, as independent variable (Fig. 1A and 1B, respectively). The experimental cut-off points, identified as the absolute peak in standardized log-rank statistics plots (vertical dotted lines in Fig. 1), were 3.7x10−4 and 3.4x10−4 residual leukemic cells for post-Ind and post-Cons values, respectively. According to this data we decided to utilize the 3.5x10−4 residual leukemic cells cut-off value to discriminate MRD− from MRD+ cases both after induction and consolidation. Therefore, patients with a residual leukemic cells values below the cutoff of 3.5×10−4 will be referred to as MRD−, while those with residual leukemic cells equal or exceeding the 3.5×10−4 level will be classified as MRD+. Post-Cons MRD− patients had a superior outcome in terms of relapse rate (27% vs. 78%, P<0.001), 7-years OS (64% vs. 14%, P<0.001) and RFS (68% vs. 13%, P<0.001). Moreover, post-Cons MRD− patients had a better outcome regardless of the MRD status after induction: in particular, patients entering MRD negativity only after consolidation showed the same outcome as those achieving early negativity after induction. Multivariate analysis, including karyotype, age, MDR1 phenotype, post-Ind and post-Cons MRD levels, indicated that the post-Cons MRD status independently affected relapse rate, OS and RFS (P<0.001, for all comparisons). In conclusion: the threshold of 3.5x10−4 is valid in discriminating risk categories in adult AML; post-consolidation MRD assessment is critical to predict disease outcome regardless of the MRD status after induction. Figure 1 Figure 1." @default.
- W2562839908 created "2017-01-06" @default.
- W2562839908 creator A5001967659 @default.
- W2562839908 creator A5004949893 @default.
- W2562839908 creator A5006168476 @default.
- W2562839908 creator A5008375828 @default.
- W2562839908 creator A5011150147 @default.
- W2562839908 creator A5025869007 @default.
- W2562839908 creator A5029157287 @default.
- W2562839908 creator A5033655270 @default.
- W2562839908 creator A5046702889 @default.
- W2562839908 creator A5051410620 @default.
- W2562839908 creator A5065398000 @default.
- W2562839908 creator A5073179633 @default.
- W2562839908 creator A5078444724 @default.
- W2562839908 creator A5080855457 @default.
- W2562839908 creator A5087110375 @default.
- W2562839908 date "2006-11-01" @default.
- W2562839908 modified "2023-09-30" @default.
- W2562839908 title "Statistical Validation of a Threshold To Discriminate Flow-Cytometry Minimal Residual Disease (MRD) Levels with Prognostic Significance in Acute Myeloid Leukemia (AML)." @default.
- W2562839908 doi "https://doi.org/10.1182/blood.v108.11.2299.2299" @default.
- W2562839908 hasPublicationYear "2006" @default.
- W2562839908 type Work @default.
- W2562839908 sameAs 2562839908 @default.
- W2562839908 citedByCount "0" @default.
- W2562839908 crossrefType "journal-article" @default.
- W2562839908 hasAuthorship W2562839908A5001967659 @default.
- W2562839908 hasAuthorship W2562839908A5004949893 @default.
- W2562839908 hasAuthorship W2562839908A5006168476 @default.
- W2562839908 hasAuthorship W2562839908A5008375828 @default.
- W2562839908 hasAuthorship W2562839908A5011150147 @default.
- W2562839908 hasAuthorship W2562839908A5025869007 @default.
- W2562839908 hasAuthorship W2562839908A5029157287 @default.
- W2562839908 hasAuthorship W2562839908A5033655270 @default.
- W2562839908 hasAuthorship W2562839908A5046702889 @default.
- W2562839908 hasAuthorship W2562839908A5051410620 @default.
- W2562839908 hasAuthorship W2562839908A5065398000 @default.
- W2562839908 hasAuthorship W2562839908A5073179633 @default.
- W2562839908 hasAuthorship W2562839908A5078444724 @default.
- W2562839908 hasAuthorship W2562839908A5080855457 @default.
- W2562839908 hasAuthorship W2562839908A5087110375 @default.
- W2562839908 hasConcept C10515644 @default.
- W2562839908 hasConcept C105795698 @default.
- W2562839908 hasConcept C11413529 @default.
- W2562839908 hasConcept C126322002 @default.
- W2562839908 hasConcept C143998085 @default.
- W2562839908 hasConcept C155512373 @default.
- W2562839908 hasConcept C203014093 @default.
- W2562839908 hasConcept C2778461978 @default.
- W2562839908 hasConcept C2778729363 @default.
- W2562839908 hasConcept C2779282312 @default.
- W2562839908 hasConcept C2779823535 @default.
- W2562839908 hasConcept C33923547 @default.
- W2562839908 hasConcept C553184892 @default.
- W2562839908 hasConcept C66339696 @default.
- W2562839908 hasConcept C71924100 @default.
- W2562839908 hasConceptScore W2562839908C10515644 @default.
- W2562839908 hasConceptScore W2562839908C105795698 @default.
- W2562839908 hasConceptScore W2562839908C11413529 @default.
- W2562839908 hasConceptScore W2562839908C126322002 @default.
- W2562839908 hasConceptScore W2562839908C143998085 @default.
- W2562839908 hasConceptScore W2562839908C155512373 @default.
- W2562839908 hasConceptScore W2562839908C203014093 @default.
- W2562839908 hasConceptScore W2562839908C2778461978 @default.
- W2562839908 hasConceptScore W2562839908C2778729363 @default.
- W2562839908 hasConceptScore W2562839908C2779282312 @default.
- W2562839908 hasConceptScore W2562839908C2779823535 @default.
- W2562839908 hasConceptScore W2562839908C33923547 @default.
- W2562839908 hasConceptScore W2562839908C553184892 @default.
- W2562839908 hasConceptScore W2562839908C66339696 @default.
- W2562839908 hasConceptScore W2562839908C71924100 @default.
- W2562839908 hasLocation W25628399081 @default.
- W2562839908 hasOpenAccess W2562839908 @default.
- W2562839908 hasPrimaryLocation W25628399081 @default.
- W2562839908 hasRelatedWork W2041569392 @default.
- W2562839908 hasRelatedWork W2076750960 @default.
- W2562839908 hasRelatedWork W2360105106 @default.
- W2562839908 hasRelatedWork W2561520560 @default.
- W2562839908 hasRelatedWork W2613654593 @default.
- W2562839908 hasRelatedWork W2760499085 @default.
- W2562839908 hasRelatedWork W2771810305 @default.
- W2562839908 hasRelatedWork W2950595403 @default.
- W2562839908 hasRelatedWork W3030698952 @default.
- W2562839908 hasRelatedWork W4223418245 @default.
- W2562839908 isParatext "false" @default.
- W2562839908 isRetracted "false" @default.
- W2562839908 magId "2562839908" @default.
- W2562839908 workType "article" @default.